ProQR Therapeutics (PRQR) Total Debt Growth (3y) (2016 - 2025)
ProQR Therapeutics (PRQR) Total Debt Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
ProQR Therapeutics |
7.27 Mn |
-100.30 Mn |
- |
-6.36% |
| Date | Value |
|---|
| Dec 31, 2025 |
-6.36% |
| Dec 31, 2024 |
-54.04% |
| Dec 31, 2023 |
-39.31% |
| Sep 30, 2023 |
-45.43% |
| Jun 30, 2023 |
-10.31% |
| Mar 31, 2023 |
-33.89% |
| Dec 31, 2022 |
-21.80% |
| Sep 30, 2022 |
-25.64% |
| Jun 30, 2022 |
51.30% |
| Mar 31, 2022 |
7,260.66% |
| Dec 31, 2021 |
67.55% |
| Sep 30, 2021 |
14,006.87% |
| Jun 30, 2021 |
41.66% |
| Mar 31, 2021 |
41.44% |
| Dec 31, 2020 |
34.29% |
| Dec 31, 2019 |
32.93% |
| Sep 30, 2019 |
1,324.46% |
| Dec 31, 2018 |
1,165.79% |
| Mar 31, 2018 |
-87.08% |
| Dec 31, 2017 |
34.35% |
